-
Survival Model Uncertainty in Economic Modeling: Evaluating Bootstrap and Cholesky Decomposition Methods
Sep 9, 2025, 16:22 PM -
EQ-5D Utility Trends in NMOSD: Impact of Time and Disability
Sep 9, 2025, 16:22 PM -
Comparative Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole for the Treatment of Invasive Aspergillosis in Algerian Hospital Setting
Sep 9, 2025, 16:22 PM -
Facilitating Investment in Obesity Care and Prevention: A Societal Cost Benefit Analysis for the Netherlands
Sep 9, 2025, 16:22 PM -
Hospital Community Integration: The Case of the Territorial Oncology Center at ASL 04 Teramo
Sep 9, 2025, 16:22 PM -
Including Decision Uncertainty About the Clinically Minimal Important Difference: Shifting From Risk Aversion to Risk Awareness in Drug Reimbursement Processes
Sep 9, 2025, 16:22 PM -
Bridging the Access Gap: The Role of Non-Public Access Partnerships for Oncology Treatments in China
Sep 9, 2025, 16:22 PM -
Comprehensive Clinical Evaluation of Drugs for Moderate-to-Severe Chronic Obstructive Pulmonary Disease
Sep 9, 2025, 16:22 PM -
A Novel Framework to Assess Noninferiority in National Institute for Health and Care Excellence (NICE) Cost-Comparison Evaluations (CCEs) Where Network Meta-Analyses (NMAs) Report Nonstatistically Significant Differences
Sep 9, 2025, 16:22 PM -
Late Treatment in Adults With Neurogenic Bowel Dysfunction: A Retrospective Analysis of German Claims Data
Sep 9, 2025, 16:22 PM -
Associations Between Waiting Time and Treatment Completion Among Treatment-Naive Pregnant Cannabis Users Admitted to Treatment Facilities in the United States
Sep 9, 2025, 16:22 PM -
Assessing the Budget Impact of Bimekizumab in the Management of Hidradenitis Suppurativa in France
Sep 9, 2025, 16:22 PM -
How Chinese Restaurants Can Help With Robust Preference Insights: A Novel Dirichlet Mixture Model to Account for Complex Heterogeneity in Individual Preference Weights
Sep 9, 2025, 16:22 PM -
Evaluating the Lifetime Incremental Value of Pharmaceutical Innovation: The Case of Non-Small Cell Lung Cancer
Sep 9, 2025, 16:22 PM -
Components of the Direct Cost of Topical Treatment for Chronic Wounds in Adults and Elderly: A Systematic Review
Sep 9, 2025, 16:22 PM -
How Far Have We Come With EQ-5D-5L Value Sets? An Updated Systematic Literature Review of 55 Valuation Studies
Sep 9, 2025, 16:22 PM -
Studying Paternal Drug Exposures and Offspring Outcomes: A Feasibility Assessment of 11 Large European Databases
Sep 9, 2025, 16:22 PM -
A Budget Impact Model of Switching From Self-Monitoring of Blood Glucose to Continuous Glucose Monitoring for Individuals With Type 2 Diabetes Mellitus Receiving Basal Insulin in Italy
Sep 9, 2025, 16:22 PM -
Distributional Cost-Effectiveness Analysis Across the Globe: How Feasible Is It Really?
Sep 9, 2025, 16:22 PM -
Societal Value of Intravitreal Injections for Retinal Vascular Diseases in the National Reimbursement Drug List in China
Sep 9, 2025, 16:22 PM
